bioRxivImmunology
Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice
Mohsen Khosravi-MaharlooeiiD, Andrea Vecchione, Nichole M. DanzliD, Hao Wei LiiD, Grace NaumaniD, Rachel Madley, Elizabeth WaffarniD, ROBERT J. WINCHESTERiD, Amanda RuiziD, Xiaolan DingiD, Georgia FousteriiD, Megan SykesiD
Abstract
Human immune system (HIS) mice constructed in various ways are widely used for investigations of human immune responses to pathogens, transplants and immunotherapies. In HIS mice that generate T cells de novo from hematopoietic progenitors, T cell-dependent multisystem autoimmune disease occurs, most rapidly when the human T cells develop in the native NOD.Cg- Prkdcscid Il2rgtm1Wjl (NSG) mouse thymus, where negative selection is abnormal. Disease develops very late when human T cells develop in human fetal thymus grafts, where robust negative selection is observed. We demonstrate here that PD-1+CD4+ peripheral (Tph) helper-like and follicular (Tfh) helper-like T cells developing in HIS mice can induce autoimmune disease. Tfh- like cells were more prominent in HIS mice with a mouse thymus, in which the highest levels of IgG were detected in plasma, compared to those with a human thymus. While circulating IgG and IgM antibodies were autoreactive to multiple mouse antigens, in vivo depletion of B cells and antibodies did not delay the development of autoimmune disease. Conversely, adoptive transfer of enriched Tfh- or Tph-like cells induced disease and autoimmunity-associated B cell phenotypes in recipient mice containing autologous human APCs without T cells. Tfh/Tph cells from mice with a human thymus expanded and induced disease more rapidly than those originating in a murine thymus, implicating HLA-restricted T cell-APC interactions in this process. Since Tfh, Tph, autoantibodies and lymphopenia-induced proliferation (LIP) have all been implicated in various forms of human autoimmune disease, the observations here provide a platform for the further dissection of human autoimmune disease mechanisms and therapies.
- organism: mouse
- organism: human
- assay: proteomics
- assay: flow cytometry
- assay: imaging
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes
M. Darguzyte, P. Amtczak, … R. Stripecke·bioRxiv·Mar 26, 2024
- IL-1β Signaling Modulates T Follicular Helper and Regulatory Cells in Human Lymphoid Tissues
Romain Vaineau, Raphaël Jeger‐Madiot, … Stéphanie Graff‐Dubois·JCI InsightPeer-reviewed·May 20, 2025
- mTORC2 contributes to murine systemic autoimmunity
- Plasmacytoid dendritic cells are functionally exhausted while non-haematopoietic sources of type I interferon dominate human autoimmunity
A. Psarras, A. Alase, … E. M. Vital·bioRxiv·Dec 20, 2018
- Accumulation of PD-1+ TIGIT+ T cells in the liver after local antigen reactivity and during autoimmune hepatitis
Thomas Guinebretière, Anaïs Cardon, … Amédée Renand·bioRxiv·Aug 29, 2025
- Histone Deacetylase 7 Mediates Tissue-Specific Autoimmunity via Control of Innate Effector Function in Invariant Natural Killer T-Cells
H. G. Kasler, I. S. Lee, … E. Verdin·bioRxiv·Oct 18, 2017